19 June 2013
Keywords: gsk, atriance, approved, ec, uk, drug, major
Article | 03 September 2007
UK drug major GlaxoSmithKline's Atriance (nelarabine solution for infusion) has received approval from the European Commission for the
treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 September 2007
© 2013 thepharmaletter.com